The European Chemicals Agency (ECHA) is consulting on potential candidates for substitution and on derogation conditions
The EU Biocidal Products Regulation 528/2012 (EU BPR) applies in NI.
If an active substance meets the exclusion criteria set out in Article 5 (1), it would not normally be approved for use in biocidal products. 2,2-dibromo-2-cyanoacetamide (DBNPA) has been identified as fulfilling at least one of the criteria set out in the Article 5 (1) exclusion criteria under EU BPR. Where an active substance meets at least one of the exclusion criteria listed in Article 5 (1), it may still be approved in accordance with Article 5 (2) if one of the following conditions are met: - the risk to humans, animals or the environment from exposure to the active substance in a biocidal product, under realistic conditions of use, is negligible
- the active substance is essential to prevent a serious danger to human or animal health or the environment
- not approving the substance would have a disproportionate negative impact on society compared to the risks
In these circumstances the active substance will also be considered as a candidate for substitution under Article 10 (1) of the EU BPR.
Before submitting its opinion on the approval or renewal of the active substance to the Commission, ECHA will launch a consultation to collect information on potential alternatives to this substance (Article 10 (3) of EU BPR). The following active substance has been identified as a potential candidate for substitution under EU BPR and ECHA has launched a public consultation running until the stated date:
Comments should be submitted to ECHA using the dedicated webforms.
Please note this consultation and its outcome are not applicable under the GB Biocidal Products Regulations (GB BPR). | 
